The USA has both Federal and State based Right to Try Laws for patients with very severe and life threatening illnesses that are not responding to FDA approved treatments. 

In Australia we have the Special Access Scheme & Authorised Prescriber Scheme Online System. The TGA has a responsibility to encourage the use of therapeutic goods that are included in the Australian Register of Therapeutic Goods (ARTG), as these products have been evaluated to ensure they meet strict standards of safety, quality and effectiveness.

The Special Access Scheme (SAS) and the Authorised Prescriber (AP) scheme allow certain registered health practitioners to access ‘unapproved’ therapeutic goods for patients under their care.

Is this sufficient or do some very ill Australians need more access to non-TGA approved treatments and also treatments banned by the TGA, that are used successfully in many other countries and that may be life saving for some patients?